{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:27:58Z","timestamp":1793683678900,"version":"4.5.1"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2018.7399","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T20:38:39Z","timestamp":1548448719000},"page":"e187399","source":"Crossref","is-referenced-by-count":299,"title":["Patterns in Outpatient Benzodiazepine Prescribing in the United States"],"prefix":"10.1001","volume":"2","author":[{"given":"Sumit D.","family":"Agarwal","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Landon","sequence":"additional","affiliation":[{"name":"Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of General Medicine and Primary Care, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"issue":"4","key":"zoi180309r1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013.","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am J Public Health"},{"issue":"4","key":"zoi180309r4","first-page":"224","article-title":"Risks associated with long-term benzodiazepine use.","volume":"88","author":"Johnson","year":"2013","journal-title":"Am Fam Physician"},{"issue":"11","key":"zoi180309r7","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults.","volume":"63","author":"American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"zoi180309r8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMp1715050","article-title":"Our other prescription drug problem.","volume":"378","author":"Lembke","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi180309r9","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1111\/jgs.13666","article-title":"Benzodiazepine prescribing in older adults in US ambulatory clinics and emergency departments (2001-10).","volume":"63","author":"Marra","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"zoi180309r10","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1111\/jgs.14379","article-title":"No end in sight: benzodiazepine use in older adults in the United States.","volume":"64","author":"Maust","year":"2016","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"zoi180309r11","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.14930","article-title":"Opioids and other central nervous system-active polypharmacy in older adults in the United States.","volume":"65","author":"Gerlach","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"zoi180309r12","doi-asserted-by":"crossref","first-page":"e180919","DOI":"10.1001\/jamanetworkopen.2018.0919","article-title":"Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare Part D beneficiaries.","volume":"1","author":"Hernandez","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi180309r13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jamapsychiatry.2018.0544","article-title":"Physician prescribing of opioids to patients at increased risk of overdose from benzodiazepine use in the United States.","volume":"75","author":"Ladapo","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"zoi180309r14","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/jamainternmed.2018.2413","article-title":"Factors associated with long-term benzodiazepine use among older adults.","volume":"178","author":"Gerlach","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"9","key":"zoi180309r15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s11606-016-3740-0","article-title":"Benzodiazepines are prescribed more frequently to patients already at risk for benzodiazepine-related adverse events in primary care.","volume":"31","author":"Kroll","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"171","key":"zoi180309r16","first-page":"1","article-title":"Nonresponse bias in estimates from the 2012 National Ambulatory Medical Care Survey.","author":"Hing","year":"2016","journal-title":"Vital Health Stat 2"},{"issue":"1","key":"zoi180309r18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-199448010-00004","article-title":"Guidelines for the rational use of benzodiazepines: when and what to use.","volume":"48","author":"Ashton","year":"1994","journal-title":"Drugs"},{"issue":"78","key":"zoi180309r20","first-page":"i","article-title":"A reason for visit classification for ambulatory care.","author":"Schneider","year":"1979","journal-title":"Vital Health Stat 2"},{"issue":"1","key":"zoi180309r21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons.","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"issue":"6","key":"zoi180309r22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/pds.3951","article-title":"Trends in prescribing of sedative-hypnotic medications in the USA: 1993-2010.","volume":"25","author":"Kaufmann","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"zoi180309r23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1176\/appi.ps.201700095","article-title":"Long-term use of benzodiazepines and nonbenzodiazepine hypnotics, 1999-2014.","volume":"69","author":"Kaufmann","year":"2018","journal-title":"Psychiatr Serv"},{"issue":"2","key":"zoi180309r24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States.","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"zoi180309r25","doi-asserted-by":"crossref","first-page":"ITC6","DOI":"10.7326\/0003-4819-159-11-201312030-01006","article-title":"In the clinic: generalized anxiety disorder.","volume":"159","author":"Patel","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi180309r26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"key":"zoi180309r27","doi-asserted-by":"crossref","first-page":"e04","DOI":"10.4088\/JCP.9058se1c.04gry","article-title":"Major depressive disorder treatment guidelines in America and Europe.","volume":"71","author":"Davidson","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"zoi180309r28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2017.6996","article-title":"Treating anxiety in 2017: optimizing care to improve outcomes.","volume":"318","author":"Stein","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"zoi180309r29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1586\/14737175.8.8.1189","article-title":"Effectiveness of benzodiazepines: do they work or not?","volume":"8","author":"Lader","year":"2008","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"zoi180309r30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/jamapsychiatry.2014.2190","article-title":"Why are benzodiazepines not yet controlled substances?","volume":"72","author":"Moore","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"zoi180309r31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jamapsychiatry.2015.0351","article-title":"Restricting benzodiazepines to short-term prescription.","volume":"72","author":"Krystal","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"49","key":"zoi180309r32","doi-asserted-by":"crossref","first-page":"15078","DOI":"10.1073\/pnas.1518393112","article-title":"Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century.","volume":"112","author":"Case","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"zoi180309r33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.annemergmed.2016.10.002","article-title":"Diazepam is no better than placebo when added to naproxen for acute low back pain.","volume":"70","author":"Friedman","year":"2017","journal-title":"Ann Emerg Med"},{"issue":"15","key":"zoi180309r34","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016.","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"zoi180309r35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pmedr.2017.12.010","article-title":"Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993-2014.","volume":"9","author":"Hirschtritt","year":"2017","journal-title":"Prev Med Rep"},{"issue":"2","key":"zoi180309r36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014","article-title":"Trends in the concomitant prescribing of opioids and benzodiazepines, 2002-2014.","volume":"51","author":"Hwang","year":"2016","journal-title":"Am J Prev Med"},{"issue":"8","key":"zoi180309r37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/pds.3776","article-title":"Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010.","volume":"24","author":"Larochelle","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"zoi180309r6","volume-title":"The CBHSQ Report","author":"Day","year":"2014"},{"key":"zoi180309r2","unstructured":"National Institute on Drug Abuse. Overdose death rates. https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates. Updated August 2018. Accessed October 3, 2017."},{"key":"zoi180309r3","unstructured":"National Center for Health Statistics. Multiple cause of death 1999-2016. https:\/\/wonder.cdc.gov\/wonder\/help\/mcd.html. Reviewed December 6, 2018. Accessed January 12, 2018."},{"key":"zoi180309r5","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Benzodiazepine abuse treatment admissions have tripled from 1998 to 2008. https:\/\/www.samhsa.gov\/newsroom\/press-announcements\/201106091200. Updated November 25, 2018. Accessed May 1, 2018."},{"key":"zoi180309r17","unstructured":"National Center for Health Statistics. NAMCS\/NHAMCS Ambulatory Health Care Data. https:\/\/www.cdc.gov\/nchs\/ahcd\/index.htm. Updated December 10, 2018. Accessed October 6, 2017."},{"key":"zoi180309r19","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm518473.htm. Updated September 20, 2017. Accessed November 3, 2017."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/2\/1\/e187399\/17310533\/agarwal_2019_oi_180309.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T16:01:15Z","timestamp":1551456075000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2018.7399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.7399","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,25]]}}}